Lincolnshire firm’s industrial workwear business acquired
Building Society calls for compulsory financial education in schools
New partnership launched to deliver new housing schemes across Yorkshire
Benchmark sells genetics business
Sheffield-based Benchmark, an aquaculture genetics, specialist nutrition, and health business, has entered into a binding agreement to sell the company’s genetics business area to Starfish Bidco, a wholly owned subsidiary of Novo Holdings.
The deal, by way of the disposal of Benchmark Genetics Limited and Benchmark Genetics Norway AS and their respective subsidiaries, represents an enterprise value of up to £260 million, including an initial consideration of £230 million and additional contingent consideration of up to £30 million.The disposal will enable the company to focus on its advanced nutrition and health business areas, and creates an opportunity to reduce complexity and streamline the current group structure to significantly reduce costs.
Trond Williksen, Benchmark CEO, said: “I am pleased to announce this agreement to sell our genetics business to Novo Holdings. The Transaction will unlock significant value and enable us to return capital to shareholders.
“The Disposal will also allow us to focus all our efforts on developing the significant potential of our continuing business areas, Advanced Nutrition and Health. In addition, it will enable us to reduce complexity and streamline the Group structure to significantly reduce costs.
“I would like to thank all our colleagues who have been working tirelessly this year to deliver a robust performance amidst difficult market conditions. Novo Holdings will be an excellent new owner of the genetics business and is in an ideal position to take the business forward.”
Aleks Engel, Partner at Novo Holdings, said: “We are very pleased to announce plans to acquire the Benchmark genetics business from Benchmark Holdings. Both animal and plant genetics hold immense potential to transform the global food industry, enabling more efficient and sustainable ways to feed a growing population.
“In particular, advancements in aquaculture genetics, such as those in the salmon industry, present significant opportunities to improve productivity, resilience, and environmental outcomes.”
Northern Gritstone leads £4m Seed investment into University of Sheffield spinout
Northern Gritstone has led a £4 million Seed investment into the University of Sheffield spinout, Exciting Instruments, the single-molecule platform company.
Single-molecule microscopy is one of the most powerful tools to understand disease and develop targeted therapies, however it has often been limited by complex workflows and limited accessibility, restricting its use so far to select and specialist research environments.
Exciting Instruments has developed and delivers a practical and efficient new platform for single-molecule detection, opening up adoption to an unconstrained user base spanning pharma, healthcare and other industrial applications.
Its platform technology allows users to visualise and analyse individual molecules and their interactions, whilst also providing high throughput processing and automation of analytics, advancements that are critical for improved efficiency and productivity.
Early customers of Exciting Instruments’ platform are already using it to drive new discoveries in drug development, clinical diagnostics and a range of research applications in both the pharmaceutical industry and within leading research laboratories.
Where incumbent approaches have failed to scale, Exciting Instruments is demonstrating a new path that will totally redefine molecular analysis and transform global health outcomes.
Co-investors into the round include Empirical Ventures, NPIF II – Praetura Equity Finance, and serial entrepreneurs Stan Boland and Jonathan Millner.
Duncan Johnson, CEO of Northern Gritstone, said: “Northern Gritstone is delighted to support Exciting Instruments’ internationally renowned team from the University of Sheffield. Their technology will open up a broad range of health-related research and discovery and will also support job creation in Sheffield’s thriving tech cluster.
“I’m particularly pleased that the funding round for Exciting Instruments has been over-subscribed which is another validation of the quality of deep tech investment opportunities that exist within the Northern Triangle.”
Tim Craggs CEO and Rob Bell COO, Co-Founders of Exciting Instruments, said: “Our vision at Exciting Instruments is to bring the power of single-molecule detection to every academic and pharma lab across the globe.
“We’re not just building technology—we’re creating a new era where single-molecule insights become the foundation for breakthroughs that will redefine what’s possible in human health.”
Sheffield businesses get sharper focus on customer metrics
£200m project will protect more than 1,000 businesses from flooding
Government plans £140m spend to create construction apprenticeships
Employers offered free advice to support abuse victims
Lincolnshire employers are being offered free training and guidance to help them support staff experiencing domestic abuse.